Expression of Ber-EP4 and CD34 can distinguish clear-cell basal cell carcinoma from trichilemmoma: A case series
Indian Journal of Dermatology, Venereology and Leprology · 2023
DOI: 10.25259/ijdvl_468_2022 ↗Kurz gefasst
Leserbrief in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2023. Verfasst von Anupam Mitra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California Davis, Sacramento, United States. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms, Hair Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of California Davis, Sacramento, United States.
- Department of Dermatology, Veteran Affairs Hospital Mather & University of California Davis, Mather, CA, United States.
Zitieren
APA
Mitra, A., & Schulman, J. M. (2023). Expression of Ber-EP4 and CD34 can distinguish clear-cell basal cell carcinoma from trichilemmoma: A case series. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_468_2022
Vancouver
Mitra A, Schulman JM. Expression of Ber-EP4 and CD34 can distinguish clear-cell basal cell carcinoma from trichilemmoma: A case series. Indian Journal of Dermatology, Venereology and Leprology. 2023. doi:10.25259/ijdvl_468_2022
BibTeX
@article{Mitra2023,
author = {Mitra, Anupam and Schulman, Joshua M},
title = {Expression of Ber-EP4 and CD34 can distinguish clear-cell basal cell carcinoma from trichilemmoma: A case series},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2023},
doi = {10.25259/ijdvl_468_2022}
}
EUVIMED